You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 109 No. 2, February 1991 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Exposure to phenothiazine drugs and risk of cataract

N. E. Isaac, A. M. Walker, H. Jick and M. Gorman
Boston Collaborative Drug Surveillance Program, Lexington, Mass.

Clinical reports have indicated an increased risk of ocular opacities in users of phenothiazine drugs, and some recent epidemiologic studies have found an association between cataract and a history of tranquilizer use. To examine the effects of major tranquilizers (phenothiazines and haloperidol) on the risk of cataract extraction, while controlling for suspected risk factors such as diabetes and steroid use, a matched cohort study was performed using information from a large health maintenance organization in Seattle, Wash. The use of either antipsychotic or other phenothiazine drugs increased the risk of cataract extraction by roughly 3.5 times in individuals who were both current users and were exposed some time in the 2 to 5 years prior to their extraction. Risk was also increased in individuals with prior use of antidiabetic agents, systemic steroids, and benzodiazepines. Contrary to some prior reports, there was no elevated risk associated with use of antihypertensives, and there was no protective effect for aspirin, acetaminophen, or ibuprofen.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Direct perturbation of lens membrane structure may contribute to cataracts caused by U18666A, an oxidosqualene cyclase inhibitor
Cenedella et al.
J. Lipid Res. 2004;45:1232-1241.
ABSTRACT | FULL TEXT  

Risk Factors for Incident Cortical and Posterior Subcapsular Lens Opacities in the Barbados Eye Studies
Hennis et al.
Arch Ophthalmol 2004;122:525-530.
ABSTRACT | FULL TEXT  

Calcium Activates SK Channels in the Intact Human Lens
Rhodes et al.
IOVS 2003;44:3927-3932.
ABSTRACT | FULL TEXT  

Cataract Occurrence With Antipsychotic Drugs
Shahzad et al.
Psychosomatics 2002;43:354-359.
ABSTRACT | FULL TEXT  

Quetiapine and Cataracts
LATIES
Am. J. Psychiatry 2002;159:322-323.
FULL TEXT  

A systematic review of drug induced ocular reactions in diabetes
Hampson and Harvey
Br. J. Ophthalmol. 2000;84:144-149.
ABSTRACT | FULL TEXT  

Chlorpromazine-Induced Refractile Corneal Deposits and Cataract
Leung et al.
Arch Ophthalmol 1999;117:1662-1663.
FULL TEXT  

Exposure to Allopurinol and the Risk of Cataract Extraction in Elderly Patients
Garbe et al.
Arch Ophthalmol 1998;116:1652-1656.
ABSTRACT | FULL TEXT  

Association of Inhaled Corticosteroid Use With Cataract Extraction in Elderly Patients
Garbe et al.
JAMA 1998;280:539-543.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1991 American Medical Association. All Rights Reserved.